Evaluation of polygenic risk scores for breast and ovarian cancer risk prediction in BRCA1 and BRCA2 mutation carriers
Karoline B. Kuchenbaecker, Lesley McGuffog, Daniel Barrowdale, Andrew Lee, Penny Soucy, Joe Dennis, Susan M. Domchek, Mark Robson, Amanda B. Spurdle, Susan J. Ramus, Nasim Mavaddat, Mary Beth Terry, Susan L. Neuhausen, Rita Katharina Schmutzler, Jacques Simard, Paul D.P. Pharoah, Kenneth Offit, Fergus J. Couch, Georgia Chenevix-Trench, Douglas F. Easton
- Wellcome Trust
- University of Cambridge
- Centre hospitalier universitaire de Québec
- Cochin Hospital
- Memorial Sloan-Kettering Cancer Center
- QIMR Berghofer Medical Research Institute
- University of New South Wales
- Garvan Institute of Medical Research
- Columbia University
- City of Hope National Medical Center
- University Hospital of Cologne
- Mayo Clinic Minnesota
- German Cancer Research Centre
- University of Melbourne
- Cancer Prevention Institute of California
- Fox Chase Cancer Center
- Huntsman Cancer Institute
- University of Utah
- University of Pretoria
- Copenhagen University Hospital
- Spanish National Cancer Research Center (CNIO)
- CIBER de Enfermedades Raras (CIBERER)
- IFOM - The FIRC Institute of Molecular Oncology
- Cogentech
- CRO (Centro di Riferimento Oncologico) Aviano National Cancer Institute
- University of Queensland
- European Institute of Oncology
- Skåne University Hospital
Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review